Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study
Clinical and Translational Radiation Oncology · 2026-07 · 59 · 101197
DOI: 10.1016/j.ctro.2026.101197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Radiation Oncology, 2026-07. Verfasst von Seok-Joo Chun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Ilsan Dongguk University Hospital, Goyang, the Republic of Korea. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seoul National University Hospital, Korea Ministry of Health and Welfare, National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Ilsan Dongguk University Hospital, Goyang, the Republic of Korea.
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea.
- Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, the Republic of Korea.
- Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.
- Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea.
Förderung
- Seoul National University Hospital
- Korea Ministry of Health and Welfare
- National Research Foundation of Korea
- Korea Health Industry Development Institute
Zitieren
APA
Chun, S. J., Kim, N., Lim, D. H., Kim, J. Y., Wee, C. W., Yoon, H. I., Jeon, S. H., Kim, I. A., & Lee, J. H. (2026). Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study. Clinical and Translational Radiation Oncology, 59, 101197. https://doi.org/10.1016/j.ctro.2026.101197
Vancouver
Chun SJ, Kim N, Lim DH, Kim JY, Wee CW, Yoon HI, et al. Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study. Clinical and Translational Radiation Oncology. 2026;59:101197. doi:10.1016/j.ctro.2026.101197
BibTeX
@article{Chun2026,
author = {Chun, Seok-Joo and Kim, Nalee and Lim, Do Hoon and Kim, Joo-Young and Wee, Chan Woo and Yoon, Hong In and Jeon, Seung Hyuck and Kim, In Ah and Lee, Joo Ho},
title = {Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study},
journal = {Clinical and Translational Radiation Oncology},
year = {2026},
volume = {59},
pages = {101197},
doi = {10.1016/j.ctro.2026.101197}
}
EUVIMED